Digital Health Intervention Based on Artificial Intelligence to Support the Personalized Recovery of Long COVID Patients Affected by Fatigue (AIDA)

Adhera Health

Status: Completed

Conditions: Post Acute COVID-19 Syndrome

Treatments: Behavioral: Adhera® Fatigue for Long COVID program

Study type: Interventional

Funder types: Industry; Other

Identifiers

NCT05483829

FAT-22-001

Details and patient eligibility

About

The AIDA feasibility study builds upon mental health and technology acceptance theoretical frameworks. It examines the feasibility of a mobile-based digital program to support patients with long covid affected by fatigue. The program Adhera ® Fatigue Self-management is adapted for long covid patients.

Full description

The study will explore the usability and engagement of a digital program designed for long covid patients affected by fatigue. The digital program relies on the Adhera® personalized digital health solution that includes personalized patient education and support, monitoring using psychometrics and wearables, and mental wellbeing exercises. The patients access the mobile solution via a mobile app. A total of 15 patients will be recruited and use the mobile solution for one month.

Enrollment: 15 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Legal adults (older than 18)

• Long COVID diagnosis within the last year

• In possession of a compatible smartphone (Android OS v4.4 or higher)

• Reporting any of these symptoms:

  • Fatigue
  • Dyspnea
  • Anxiety
  • Stress
  • Depression
  • Sleep disorder

Exclusion criteria

• Hospital admission during follow-up due to pathology not related to COVID-19
• Patients without digital literacy or who cannot use the mobile application.
• Known severe psychiatric illness or cognitive impairment
• Being pregnant (or suspected to be pregnant)

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

15 participants in 1 patient group

Long COVID prospective group

Experimental group

Treatment:

Behavioral: Adhera® Fatigue for Long COVID program